Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2000
12/07/2000WO2000073798A1 Vesicle containing polymers and sensor detection methods based thereon
12/07/2000WO2000073797A2 Homogeneous tests for sequentially determining lipoprotein fractions
12/07/2000WO2000073796A2 Ligand-anchor conjugates for producing a biosensor layer
12/07/2000WO2000073794A2 Method for separating cells using immunorosettes
12/07/2000WO2000073793A2 Identification of compounds modulating insulin receptor activity
12/07/2000WO2000073792A1 Control for methods for determining platelet count and platelet function
12/07/2000WO2000073791A1 Remedies for kidney diseases and method for screening the same
12/07/2000WO2000073790A1 Test system for in-vitro detection of an antigen-specific immune response
12/07/2000WO2000073788A1 Use of gabapentin in assays to identify gabab receptor modulators
12/07/2000WO2000073787A1 An expert system for protein identification using mass spectrometric information combined with database searching
12/07/2000WO2000073786A2 Device for measuring the frictional properties of textile fibers
12/07/2000WO2000073784A2 Devices and methods for assessing cellular transport for research, drug discovery and testing, clinical diagnoses, and therapy design
12/07/2000WO2000073777A1 Array cytometry
12/07/2000WO2000073775A1 Device for measuring the concentration of hydrogen in a gas mixture
12/07/2000WO2000073771A1 Method and device for detecting foreign matter in a fibre composite moving in the longitudinal direction
12/07/2000WO2000073766A1 Genetic assay system
12/07/2000WO2000073765A1 Device for removing slag samples
12/07/2000WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence
12/07/2000WO2000073763A2 SYSTEMS AND METHODS OF pH TISSUE MONITORING
12/07/2000WO2000073511A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073504A2 Microarray chip and method for indexing the same
12/07/2000WO2000073501A2 Nucleic acid molecules with specific identification of native prpsc, their production and the use thereof
12/07/2000WO2000073497A1 Reporter molecules and methods for assaying the lipidation status of a cell
12/07/2000WO2000073493A2 A nematode drug screen for modulators of mammalian disorders
12/07/2000WO2000073492A1 Rapid immunoassay for cariogenic bacteria
12/07/2000WO2000073491A2 Novel method for investigating the suitability of a material as a medicament
12/07/2000WO2000073469A2 Protein kinases
12/07/2000WO2000073464A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000WO2000073459A1 Four-helical bundle protein zsig81
12/07/2000WO2000073458A1 Secreted alpha-helical protein-31
12/07/2000WO2000073454A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/07/2000WO2000073453A1 T-bet compositions and methods of use thereof
12/07/2000WO2000073452A2 Compositions and methods for the treatment of immune related diseases
12/07/2000WO2000073451A1 Mammalian receptor proteins; related reagents and methods
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073448A1 Adipocyte complement related protein homolog zacrp7
12/07/2000WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3)
12/07/2000WO2000073444A1 Adipocyte complement related protein homolog zacrp5
12/07/2000WO2000073443A1 Lipid metabolism transcription factor
12/07/2000WO2000073442A1 Novel cytokine
12/07/2000WO2000073438A1 Tumor-associated antigen (c42)
12/07/2000WO2000073431A2 Methods and compositions for measuring ion channel conductance
12/07/2000WO2000073420A2 Creation of human tumorigenic cells and uses therefor
12/07/2000WO2000073419A1 Immortalized human middle ear epithelial cell lines
12/07/2000WO2000073417A1 In vitro cell culture device including cartilage and methods of using the same
12/07/2000WO2000073413A2 Apparatus and method for cell disruption
12/07/2000WO2000073412A2 Apparatus and method for analyzing a fluid sample
12/07/2000WO2000073346A1 Immunoconjugates having high binding affinity
12/07/2000WO2000073345A2 Antibodies specific for mycobacterial polypeptides and uses thereof
12/07/2000WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073338A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000WO2000073334A2 Human sorting nexins
12/07/2000WO2000073330A2 Method and compositions relating to insulin resistance disorders
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000072970A1 Cartridge for conducting a chemical reaction
12/07/2000WO2000072880A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072877A1 Rapid immunoassay to detect antibodies in saliva to disease-related antigens
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072869A1 Methods for producing 5'-nucleic acid-protein conjugates
12/07/2000WO2000072834A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
12/07/2000WO2000072742A2 Methods and materials for generating sh3 domains with tailored binding properties
12/07/2000WO2000072679A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000WO2000072666A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE
12/07/2000WO2000072652A2 Method for imaging logs or stems and apparatus
12/07/2000WO2000062061A8 Device and method for use in receptor-ligand and affinity tests
12/07/2000WO2000050631A3 Compositions and methods for monitoring the modification of natural binding partners
12/07/2000WO2000050565A3 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/07/2000WO2000049408A3 Method for providing a stabilized myoglobin biochemical reagent
12/07/2000WO2000048703B1 Purification of biological substances
12/07/2000WO2000047997A3 Anti-lamin antibodies, endogenous inhibitors of thrombosis
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
12/07/2000WO2000045179A3 Screening for modulators of g-protein subunit beta 3
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
12/07/2000WO2000043519A3 Neisseria meningitidis polypeptides
12/07/2000WO2000042205A3 Herbicide target gene and methods
12/07/2000WO2000036407A9 Separation of charged particles by a spatially and temporally varying electric field
12/07/2000WO2000036393A9 Method and apparatus for automated reprocessing of tissue samples
12/07/2000WO2000033062A9 Aligned particle based sensor elements
12/07/2000WO2000031539A9 Method and apparatus for performing a lateral flow assay
12/07/2000WO2000024390A9 Method and composition for modulating amyloidosis
12/07/2000DE19925405A1 Verfahren zum Nachweis von spezifisch antigenreaktiven Lymphozyten sowie ein Nachweis-Kit zur Durchführung dieses Verfahrens A method for the detection of specific antigen reactive lymphocytes, as well as a detection kit for performing this method
12/07/2000DE19925235A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19924741A1 Meßvorrichtung für die Reibeigenschaften von textilen Fäden Device for measuring the frictional properties of textile fibers
12/07/2000DE19923811C1 Verfahren zur Diagnose TSE-induzierter Veränderungen in Geweben mittels Infrarotspektroskopie A method of diagnosing TSE-induced changes in tissues by means of infrared spectroscopy
12/07/2000DE19923139A1 Verfahren und Vorrichtung zum Aufschluß einer wässrigen Lösung zur Kohlenstoffgehaltsbestimmung Method and apparatus for the decomposition of an aqueous solution of carbon content determination
12/07/2000DE19921691A1 Determining the mitogenic or antimitogenic potential of a substance or environmental condition comprises determining the proportions of cells in different phases of the cell cycle using monoclonal antibodies
12/07/2000DE19921304A1 Lubricant test method for using in roller bearings by forming histogram of statistical frequencies of location-dependent measurements
12/07/2000DE19919351C1 Laboratory process to determine soil subsidence resulting from water ingress in geological, mining, soil mechanics and soil physics applications
12/07/2000DE19918569A1 Rapid diagnostic specific-binding assay, useful in human or veterinary medicine, comprises specific binding reagent immobilized on polymer surface through linkers
12/07/2000CA2725132A1 Method for separating cells using immunorosettes
12/07/2000CA2414214A1 Four-helical bundle protein zsig81
12/07/2000CA2383254A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2378737A1 Adipocyte complement related protein homolog zacrp5
12/07/2000CA2376133A1 Tumor-associated antigen (c42)
12/07/2000CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/07/2000CA2375888A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy